RT Journal Article
SR Electronic
T1 Decentralized governance may lead to higher infection levels and sub-optimal releases of quarantines amid the COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.20.20108167
DO 10.1101/2020.05.20.20108167
A1 Lampert, Adam
YR 2022
UL http://medrxiv.org/content/early/2022/02/11/2020.05.20.20108167.abstract
AB The outbreak of the novel Coronavirus (COVID-19) has led countries worldwide to administer quarantine policies. However, each country or state decides independently what mobility restrictions to administer within its borders, while aiming to maximize its own citizens’ welfare. Since individuals travel between countries and states, the policy in one country affects the infection levels in other countries. Therefore, major question is whether the policies dictated by multiple governments could be efficient. Here we focus on the decision regarding the timing of releasing quarantines, which were common during the first year of the pandemic. We consider a game-theoretical epidemiological model in which each government decides when to switch from a restrictive to a non-restrictive quarantine and vice versa. We show that, if travel between countries is frequent, then the policy dictated by multiple governments is sub-optimal. But if international travel is restricted, then the policy may become optimal.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundings to declareAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:no special approval required, no experiments were conductedI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSome parameter values are taken from estimates in the literature and some are estimated from publically available datasets (see Method: Parameterization). All the data and parameter values needed to regenerate the results shown in the figures are given in Methods.